Skip to main content
Liaoning Cheng Da Co.,Ltd. logo

Liaoning Cheng Da Co.,Ltd. — Investor Relations & Filings

Ticker · 600739 ISIN · CNE000000LY3 LEI · 300300ZCCWKNUJRL8D79 Shanghai Stock Exchange Financial and insurance activities
Open in API
Filings indexed 2,288 across all filing types
Latest filing 2023-04-14 Regulatory Filings
Country CN China
Listing Shanghai Stock Exchange 600739

About Liaoning Cheng Da Co.,Ltd.

https://en.chengda.com.cn/

Liaoning Cheng Da Co., Ltd. is a diversified conglomerate operating across several strategic sectors, including biopharmaceuticals, financial services, energy development, and international trade. The company is a prominent player in the biopharmaceutical field through its specialized subsidiaries, focusing on the research, development, and production of human vaccines, most notably its market-leading purified Vero cell rabies vaccine. In the energy sector, it engages in the extraction and processing of oil shale. Its financial services division involves significant investments in securities firms and insurance companies. Additionally, the company maintains a robust international trade business, dealing in commodities such as textiles and chemicals. Liaoning Cheng Da focuses on integrating industrial operations with financial capital to drive growth across its various business units.

Recent filings

Filing Released Lang Actions
辽宁成大股份有限公司关于计提减值准备的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from the board of directors of 辽宁成大股份有限公司 regarding the provision for asset impairment. It details the amounts and rationale for impairment provisions on various assets as of the end of 2022, including credit impairment losses, inventory write-downs, and long-term asset impairment. The document includes statements from the board, independent directors, and the supervisory board confirming the appropriateness and compliance of the impairment provisions with accounting standards. The document is relatively short (1246 characters) and is an announcement of a specific accounting action rather than a full financial report or audit report. It does not contain comprehensive financial statements or detailed audit opinions but rather a disclosure of impairment provisions and related approvals. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2023-04-14 Chinese
辽宁成大股份有限公司2022年度审计报告
Audit Report / Information Classification · 100% confidence The document is titled '审计报告' which translates to 'Audit Report'. It is issued by an accounting firm (容诚会计师事务所) and includes detailed audit opinions, basis for audit opinions, key audit matters, and responsibilities of management and auditors. The document contains comprehensive financial statements such as consolidated balance sheets, profit and loss statements, cash flow statements, and notes to the financial statements. The audit report covers the fiscal year ending December 31, 2022. The length of the document is substantial (15,000 characters), indicating it is the full audit report rather than a brief announcement or certification. Therefore, this document fits the category of an Audit Report / Information (AR).
2023-04-14 Chinese
辽宁成大股份有限公司独立董事关于公司对外担保情况的专项说明和独立意见
Regulatory Filings Classification · 95% confidence The document is a special statement and independent opinion by independent directors regarding the company's external guarantees for the year 2022, referencing regulatory requirements by the China Securities Regulatory Commission. It is a compliance and assurance type document related to external guarantees, not a full audit report or annual report. The document length is short (410 characters), and it is a specific regulatory compliance statement rather than a full financial report. It does not fit into categories like Annual Report, Audit Report, or Interim Report. It is best classified under Regulatory Filings (RNS) as it is a regulatory compliance disclosure that does not fit other specific categories.
2023-04-14 Chinese
辽宁成大股份有限公司关于以集中竞价交易方式回购公司股份的进展公告
Transaction in Own Shares Classification · 95% confidence The document is an announcement regarding the progress of the company's share repurchase program, detailing the number of shares repurchased, the price range, and total funds used. It references prior approvals and related announcements about the share buyback plan. The content focuses on updates about the company's own share transactions rather than financial results, management changes, or regulatory filings. This matches the definition of a Transaction in Own Shares (POS) filing, which reports on the company's buyback or sale of its own shares. The document length is under 5,000 characters and contains substantive details about the repurchase progress, not just a notice of report publication or a certification. Therefore, the correct classification is POS with high confidence.
2023-04-03 Chinese
辽宁成大股份有限公司关于公司短期融资券获准注册事项的公告
Capital/Financing Update Classification · 95% confidence The document is a short announcement regarding the approval of the company's short-term financing bond registration by the China Interbank Market Dealers Association. It mentions the registration amount, validity period, and underwriting banks. The document is brief (489 characters) and serves as a notification of a financing activity rather than a detailed financial report or analysis. It does not contain financial statements or detailed financial data. Therefore, it fits the category of a Capital/Financing Update (CAP).
2023-03-30 Chinese
辽宁成大股份有限公司关于股东股份质押延期购回的公告
Regulatory Filings Classification · 95% confidence The document is a public announcement from a company regarding the extension of the pledge and repurchase of shareholder shares. It details the number of shares pledged, the shareholders involved, and the terms of the pledge extension. There is no financial statement, earnings data, or management discussion. The document is a specific announcement about share pledge extension, which relates to shareholding and capital structure but is not a financing update or capital raising event. It is not a report or presentation but an official announcement about share pledge status. This fits best under the category of Regulatory Filings (RNS) as it is a regulatory disclosure about share pledge status that does not fit other more specific categories.
2023-03-28 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.